TCL Archive Annual Report Finds Cancer Incidence And Death Rates Fell For First Time. December 5, 2008
TCL Archive Is $45 Million Too Much to Spend on PR? NCAB Panel Weighs NCI Communications Budget December 7, 2012
TCL Archive In Brief: Levin Leaves UCSF for M.D. Anderson; Copeland Moves to Ohio State; OC’s Alice Hamm Retires July 1, 1988
TCL Archive Markup Completed On Senate Cancer Act Renewal; Waxman Agrees To $90 Million Centers Line Item May 2, 1980
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
